Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥153.30 Million ≈ $22.43 Million USD) by net assets (CN¥8.80 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tianjin Chase Sun Pharmaceutical Co Ltd (300026) market capitalisation for the company's overall valuation and market capitalisation.

Tianjin Chase Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Tianjin Chase Sun Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Qingdao NovelBeam Technology Co. Ltd. A SHG:688677	0.032x
Der International Home Furnishing Co Ltd SHE:002631	-0.007x
China National Accord Medicines Corp Ltd SHE:000028	-0.020x
Beach Energy Ltd AU:BPT	0.140x
Companhiade Eletricidade do Estado da Bahia - COELBA SA:CEEB3	-0.001x
Aura Investments Ltd TA:AURA	-0.169x
PCBL LIMITED NSE:PCBL	0.205x
Shunsin Technology Holdings Ltd TW:6451	-0.044x

Annual Cash Flow Conversion Efficiency for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. View Tianjin Chase Sun Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.80 Billion ≈ $1.29 Billion	CN¥852.24 Million ≈ $124.71 Million	0.097x	-43.86%
2023-12-31	CN¥8.87 Billion ≈ $1.30 Billion	CN¥1.53 Billion ≈ $223.90 Million	0.173x	+95.92%
2022-12-31	CN¥8.46 Billion ≈ $1.24 Billion	CN¥745.35 Million ≈ $109.07 Million	0.088x	+78.85%
2021-12-31	CN¥7.95 Billion ≈ $1.16 Billion	CN¥391.60 Million ≈ $57.30 Million	0.049x	+85.09%
2020-12-31	CN¥7.39 Billion ≈ $1.08 Billion	CN¥196.66 Million ≈ $28.78 Million	0.027x	-12.96%
2019-12-31	CN¥7.07 Billion ≈ $1.03 Billion	CN¥216.10 Million ≈ $31.62 Million	0.031x	-48.22%
2018-12-31	CN¥6.58 Billion ≈ $962.28 Million	CN¥388.19 Million ≈ $56.81 Million	0.059x	-48.25%
2017-12-31	CN¥6.51 Billion ≈ $952.41 Million	CN¥742.38 Million ≈ $108.63 Million	0.114x	+53.72%
2016-12-31	CN¥6.04 Billion ≈ $883.64 Million	CN¥448.08 Million ≈ $65.57 Million	0.074x	+224.40%
2015-12-31	CN¥5.29 Billion ≈ $774.07 Million	CN¥121.00 Million ≈ $17.71 Million	0.023x	-64.02%
2014-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥149.94 Million ≈ $21.94 Million	0.064x	-24.62%
2013-12-31	CN¥1.70 Billion ≈ $249.14 Million	CN¥143.60 Million ≈ $21.01 Million	0.084x	-23.17%
2012-12-31	CN¥1.39 Billion ≈ $202.91 Million	CN¥152.21 Million ≈ $22.27 Million	0.110x	+223.42%
2011-12-31	CN¥1.05 Billion ≈ $153.65 Million	CN¥35.64 Million ≈ $5.22 Million	0.034x	-19.44%
2010-12-31	CN¥1.10 Billion ≈ $160.63 Million	CN¥46.25 Million ≈ $6.77 Million	0.042x	-71.09%
2009-12-31	CN¥926.88 Million ≈ $135.63 Million	CN¥135.06 Million ≈ $19.76 Million	0.146x	-76.47%
2008-12-31	CN¥125.51 Million ≈ $18.37 Million	CN¥77.74 Million ≈ $11.38 Million	0.619x	-47.33%
2007-12-31	CN¥61.24 Million ≈ $8.96 Million	CN¥72.01 Million ≈ $10.54 Million	1.176x	+1943.30%
2006-12-31	CN¥21.28 Million ≈ $3.11 Million	CN¥1.22 Million ≈ $179.15K	0.058x	--

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.40 Billion

CN¥9.58 Billion CNY

Market Cap Rank

#7504 Global

#1635 in China

Share Price

CN¥3.19

Change (1 day)

+0.31%

52-Week Range

CN¥2.90 - CN¥3.95

All Time High

CN¥9.11